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Summary
Aim
Insulin sensitivity is ~40% lower in women with polycystic ovary syndrome (PCOS) than
in controls. We tested the hypothesis that 5weeks of electroacupuncture treatment im-
proves glucose regulation and androgen levels in overweight/obese women with PCOS.
Material and Methods
Seventeen women with PCOS, aged 18 to 38years, with a body mass index (BMI) ≥25
kg/m2 and diagnosed with PCOS were included in this experimental and feasibility study
and subjected to five weeks of electroacupuncture treatments three times/week. The pri-
mary outcome was changes in whole‐body glucose homeostasis measured by
euglycemic hyperinsulinemic clamp before and after the intervention. Secondary out-
come were changes in HbA1c, circulating catecholamines, adipocyte size and adipose
tissue expression of sex steroids and nerve growth factor (NGF).
Results
No significant change in glucose homeostasis was observed, but HbA1c decreased by
9.5% (p=0.004), circulating testosterone decreased by 22% (p=0.0007) and dihydrotes-
tosterone decreased by 12% (p=0.007). The two vagal activity markers of plasma sero-
tonin levels and the dopamine metabolite homovanillic acid decreased by 21% (p=0.027)
and 20% (p=0.011), respectively. Adipose tissue concentrations of testosterone
decreased by 18% (p=0.049), and androstenedione decreased by 13% (p=0.035), and
mature NGF/proNGF ratio, a marker of sympathetic activity, increased (p=0.04). These
changes occurred without changes in anthropometrics.
Conclusion
Five weeks of electroacupuncture treatment improves HbA1c and circulating and adipose
tissue androgens in women with PCOS. This effect is mediated, at least in part, via
modulation of vagal activity and adipose tissue sympathetic activity. Based on these
findings, we have recently initiated a randomized controlled study (NTC02647827).
Keywords: Acupuncture, adipose tissue, hyperandrogenism, insulin resistance, sym-
pathetic nervous system.
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Introduction
Women with polycystic ovary syndrome (PCOS) have a
three to sevenfold increased risk of developing type 2
diabetes, and this is a major health burden (1). Indepen-
dent of body weight, insulin sensitivity is ~40% lower in
women with PCOS than in controls, and insulin resistance
has been attributed to defects in insulin signaling in
adipocytes and skeletal muscle (2). Further, women with
PCOS display both insulin resistance and reduced insulin
responsiveness (2). Compensatory hyperinsulinemia fuels
ovarian androgen production and secretion by theca cells
and reduces sex hormone binding globulin (SHBG), which
in turn increases free androgen levels and further exacer-
bates PCOS symptoms (3). Conversely, female rats that
are continuously exposed to dihydrotestosterone (DHT)
from puberty exhibit irregular estrous cycles, insulin resis-
tance and obesity (4). Thus, there is a strong association
between hyperinsulinemia and hyperandrogenemia that
creates a vicious circle. Further, hyperandrogenism is
strongly associated with high sympathetic nerve activity
in women with PCOS (5), and sympathetic nerve activity
increases in response to hyperinsulinemia (6). Whether
sympathetic activation is a cause or a consequence of
metabolic disturbances is unclear.
Overweight and obesity are closely linked to the devel-
opment of PCOS. Moreover, women with PCOS have
enlarged adipocytes, which might in part explain the insu-
lin resistance in women with PCOS (7). This highlights the
role of adipose tissue dysfunction as an important mech-
anism by which adipose tissue can negatively affect
metabolic health.
Women with PCOS require long‐term individualized
treatment programs. Pharmacological treatments, includ-
ing the glucose‐reducing drug metformin, have limitations
related to adverse effects and patient compliance (8).
Therefore, there is a need for inexpensive and easily
administered treatments with few negative side effects.
Lifestyle management, including exercise and dietary
changes, is the first line of treatment for improving
whole‐body glucose homeostasis and preventing type 2
diabetes, and if successful it has the potential to improve
most PCOS‐related symptoms (8). Recently, it was dem-
onstrated that lifestyle modification with a targeted weight
loss of 7% has beneficial metabolic and reproductive
effects (9). For those who have difficulties in performing
exercise or who are not able to follow a diet, alternative
treatments such as acupuncture might be needed.
Acupuncture needles inserted into the muscle and fat
tissue and stimulated manually by rotation initiate a
specific patternof afferent activity inA‐delta fibers andC‐fi-
bers (10). When needles are stimulated by low‐frequency
(2Hz) electrical stimulation, i.e. electroacupuncture, they
cause muscle contractions that activate specific physio-
logical pathways similar to those from voluntary muscle
contractions during exercise (11). Both exercise and
low‐frequency electroacupuncture have been demon-
strated to increase ovulation rates and decrease circulat-
ing androgens in women with PCOS (12,13), and
this effect is at least in part mediated through a decrease
in muscle sympathetic nerve activity in women with
PCOS (14). The activation of sensory afferents that
innervate the skin, fat and muscle by low‐frequency
electroacupuncture might locally affect glucose uptake
by increasing the glucose transporter 4 (GLUT4) concen-
tration (15) as well as by increasing the microcirculation
through the release of a number of neuropeptides (11). It
also modulates sympathetic efferent activity at the spinal
and supraspinal level (11,16). The dosage of acupuncture
is a continuous matter of discussion, and a number of pa-
rameters can affect the physiological responses to acu-
puncture treatment, including the number of needles
used, the placement of the needles, the type of stimula-
tion (manual rotation of the needles or electrical stimula-
tion with different frequencies) and the frequency,
duration and total number of treatments. In the present
study, we decided to give acupuncture 3 times/week be-
cause lower treatment frequency (1–2 times/week) did
not improve insulin sensitivity in women with PCOS (17).
Comparisons between manual stimulation and electrical
stimulation of the needles demonstrate that
electroacupuncture improves insulin sensitivity and mod-
ulates skeletal muscle gene and protein expression more
than manual stimulation of the needles in rats (18). In the
present study, we combined electrical stimulation with
manual stimulation of needles which is a common stimu-
lation paradigm in the clinic. The placement of the
needles is another important factor, and if placed in the
same innervation area as an organ, they might directly
modulate the organ’s autonomic activity. In the present
study, the needles were placed in the same innervation
area as the pancreas and ovaries as well as at distal
points in the hands and feet to enhance the effect of local
needles (11). Of note, the activation of adrenergic path-
ways has been shown to stimulate glucose uptake, and
this provides new opportunities for the treatment of type
2 diabetes (19). Further, electroacupuncture has the po-
tential to modulate the vagal activity of the immune sys-
tem, an effect that is mediated via dopamine (20).
Whether or not acupuncture has such an effect in over-
weight or obese women with PCOS is unknown.
In this experimental and feasibility study, we tested
the hypothesis that 5 weeks of low‐frequency
electroacupuncture treatment given three times per week
results in clinically improved glucose uptake and
improved levels of HbA1c and circulating sex steroids in
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women with PCOS. We also hypothesized that improve-
ments in glucose control are related to changes in adi-
pose tissue sex steroid metabolism, to the expression of
pro‐ and mature (m) nerve growth factor (NGF) (markers
of sympathetic nerve activity), to changes in plasma nor-
adrenaline and to vagal activity as reflected by dopamine
turnover as measured by plasma dopamine, the dopa-
mine metabolites 3,4‐dihydroxyphenylacetic acid
(DOPAC) and homovanillic acid (HVA), and serotonin
and its metabolite 5‐hydroxyinoleacetic acid (5‐HIAA).
Research design and methods
This prospective clinical study was conducted at the
Sahlgrenska Academy at the University of Gothenburg,
Sweden, in accordance with the Declaration of Helsinki
and was approved by the Regional Ethical Review Board
of the University of Gothenburg. All participants gave oral
and written consent before inclusion. The study was
registered at ClinicalTrials.gov (NTC01457209) and is
reported according to the CONSORT and STRICTA
guidelines (21).
Study participants
Overweight/obese, body mass index (BMI) (kg/m2 ≥25 to
<35) women 18 to 38 years of age with PCOS were
recruited by advertisements in local newspapers, in the
community and at medical clinics between October
2011 and December 2013 in the Västra Götaland region,
Sweden. PCOS was diagnosed as having two out of the
following three Rotterdam criteria (22): polycystic ovaries
verified by ultrasound, oligo/amenorrhea (>35days or
<6 menstrual bleedings in the past year) or amenorrhea
(total absence of menstrual bleeding in the past 90days),
and clinical signs of hyperandrogenism defined by a self‐
reported Ferriman–Gallwey (FG) score ≥8. Women were
excluded if they had taken any pharmacological treat-
ments in the previous 3months, had received acupunc-
ture the last 2months or had breastfed during the last 6
months prior to the study. Other endocrine disorders,
including thyroid disease and prolactin excess, were
excluded as well as those with type 1 diabetes and
cardiovascular disease. Further exclusion criteria were a
history of daily smoking or alcohol consumption.
Study procedure
Baseline measurements started at 7:30a.m. after an over-
night fast and were performed at day 1 to 10 of a sponta-
neous cycle or independent of cycle stage because the
majority of the participants had oligo/amenorrhea.
Anthropometric measurements, including body weight
and height, were taken in an upright position with light
clothing and no shoes. BMI was calculated as body weight
(kg) divided by body height (m) squared. Waist
circumference was measured in centimeters at the
midpoint between the iliac crest and lower rib margin at
the end of expiration while standing and without clothing.
Hip circumference was measured in centimeters at the
widest point between waist and thighs and waist–hip ratio
(WHR) was calculated. Body composition, including fat
mass (%) and muscle mass (%), was measured with a
Tanita foot‐to‐foot bioelectrical impedance device
(Middlesex, UK), and blood pressure was calculated as
the mean arterial blood pressure (MAP) of three measures.
Before the start of the euglycemic hyperinsulinemic
clamp, blood samples were taken for later analysis of
luteinizing hormone (LH), follicle stimulating hormone
(FSH), sex hormone binding globulin (SHBG), testoster-
one, DHT, dehydroepiandrosterone (DHEA), androstene-
dione, estrone (E1), estradiol (E2), triglycerides, total
cholesterol, apolipoprotein A (ApoA) and B (ApoB), HbA1c,
insulin, C‐peptide and glucose as well as noradrenaline,
dopamine, the dopamine metabolites DOPAC and HVA,
serotonin and the serotonin metabolite 5HIAA.
Insulin sensitivity
The clamp examination was performed as described (23).
In brief, insulin (Actrapid, 100IU/mL; Novo Nordisk,
Bagsvaerd, Denmark) was infused at 500mU/mL in
isotonic saline containing 2mL of plasma from the subject
to prevent insulin loss. A 10‐min primed insulin infusion
was followed by a constant infusion (40mU·m−2·min−1)
for 120min to reach steady state. The blood glucose
levels were determined before infusion, every 10min dur-
ing the first 90min of infusion, and every 5min during the
last 30min of infusion. Euglycemia was maintained by
infusing 20% glucose (1.11mol/L), and the rate was
adjusted to maintain a glucose level of 5.5mmol/L. The
mean glucose infusion rate (GIR) was calculated as
M/Iclamp where M is mg glucose per kg body weight per
minute, and Iclamp is insulin levels during the last 30
min of the clamp. The homeostasis model assessment
of insulin resistance (HOMA‐IR) was calculated as fasting
glucose (mmol/L)×fasting insulin (mU/L)/22.5, and the C‐
peptide index (CPI) was calculated as fasting C‐peptide
(nmol/L)/fasting glucose (mmol/L)×100.
Adipose tissue biopsy
At baseline, a needle biopsy of subcutaneous abdominal
adipose tissue was obtained under local anaesthesia at
two‐thirds of the distance from the iliac crest to the umbi-
licus. One part was snap frozen in liquid nitrogen, and one
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part was immediately isolated to determine adipocyte
size as described (7).
All baseline measurements were repeated within 48h
after the last acupuncture treatment day 1 to 10 of a
spontaneous cycle or independent of cycle stage.
Intervention
The intervention started within one week after the base-
line measurements were taken. We used a Western med-
icine style of acupuncture, referred to as low‐frequency
electroacupuncture, with a fixed protocol based on previ-
ous studies of acupuncture in women with PCOS (12,13)
and on experimental studies (15,24,25). Two therapists
educated and experienced in Western medical acupunc-
ture delivered the acupuncture. Treatment was given
three times per week over 5weeks, and every treatment
lasted for 30min. Two sets of needle placements were al-
ternated for every other treatment to avoid soreness
(Supplemental Table 1). Needles were inserted to a depth
of 15–40mm with the aim of reaching the muscles and
structures in the hands, abdominal muscle, quadriceps
muscle and lower legs with innervation corresponding to
the ovaries and uterus. All acupuncture points, the num-
ber of needles and the stimulation are given in Supple-
mental Table 1. The needles were sterile stainless steel
(Hegu Xeno, Hegu Svenska) with a length of 30 or 50
mm and a diameter of 0.30mm. When inserted, all
needles were rotated manually to evoke needle sensation
(de qi). Needles placed in the abdominal and quadriceps
muscles were connected to an electrical stimulator
(CEFAR ACUS 4; Cefar‐Compex Scandinavia, Landsbro,
Sweden) and stimulated with a low‐frequency (2Hz)
electrical signal. The intensity was adjusted to produce
local muscle contractions without pain or discomfort
and was adjusted every 10th minute, which was when
all needles not connected to the electrical stimulator were
stimulated by manual rotations to evoke de qi (Supple-
mental Table 1).
Biochemical analyses, adipose tissue extraction
and western blot
Plasma glucose was measured with a One Touch Ul-
tra2 (LifeScan). Insulin, HbA1c, total cholesterol, tri-
glycerides, ApoA, ApoB, SHBG, LH and FSH were
analysed by an accredited laboratory at the Depart-
ment of Clinical Chemistry of Sahlgrenska University
Hospital. Serum C‐peptide was measured with a hu-
man diabetes C‐peptide magnetic bead set
(#171B7003M, Bio‐Rad, USA). Testosterone, DHT,
DHEA, E1, E2, androstendione and progesterone in se-
rum and adipose tissue were measured by gas
chromatography‐tandem mass spectrometry (GC‐MS/
MS) as described previously (26). For analyses of sex
steroids in adipose tissue, biopsies were homogenized
in 0.45mL PBS buffer and frozen at −80°C.
Measurement of plasma noradrenaline, dopamine,
DOPAC, HVA, serotonin and 5HIAA was performed with
a split fraction HPLC‐ED system as described (27).
For western blot, adipose tissue samples (1mg) were
homogenized by mechanical dissociation in 10 μL ice
cold lysis buffer (20mM Tris pH7.4, 150mM NaCl, 10%
glycerol, 1mM EDTA pH8.0, 20mM NaF, 30mM sodium
pyrophosphate (Na4P7O2), and protease and phospha-
tase cocktail inhibitors (cat P8340, P5276 and P0044,
Sigma)) without detergent using a polytron. The samples
were centrifuged at 3,000×g for 6min at 4°C to remove
the fat cake, and the supernatant was retained as the
sample. Five volumes of ice cold supplemented detergent
mix (6% NP40, 0.6% SDS, 1.5% NaDOC) was added to
each sample followed by incubation and shaking for 45
min on ice. The samples were then centrifuged at
13,000rpm for 20min at 4°C. Protein concentration was
quantified by the Bradford assay.
Adipose tissue protein concentration of mature mNGF
and proNGF were detected and quantified using
MAB5260Z clone 27/21 and EP1318Y antibodies (Merck
Millipore), respectively, in a homemade sandwich ELISA
device.
Western blot analysis for proNGF, p75NTR, phospho‐
TrkA and GAPDH was performed on six tissue samples
from each group. Samples (30µg of total protein) were
separated by 8% or 12% SDS‐PAGE and electrophoreti-
cally transferred to a PVDF membrane overnight. The
membranes were then blocked and incubated with spe-
cific antibodies (SantaCruz Biotech, CA, USA). After
washing, the membranes were incubated with horserad-
ish peroxidase‐conjugated anti‐rabbit IgG or horseradish
peroxidase‐conjugated anti‐mouse IgG as the secondary
antibody (Cell Signaling Technology, MA, USA) at room
temperature. The blots were developed with an ECL as-
say (Millipore, MA, USA). The GAPDH bands were used
as a control for equal protein loading. The ImageJ soft-
ware (http://rsb.info.nih.gov/ij/) was used for gel densi-
tometry and protein quantification.
Sample size calculation
The sample size for detecting changes in glucose uptake
as measured by the euglycemic hyperinsulinemic clamp
was determined based on a previous study with a similar
design but with exercise instead of acupuncture (28). We
expected a ΔM/Iclamp change of 1.5 with a standard devi-
ation (SD) of 2 from baseline after 5weeks of the interven-
tion. With a target power of 80% and the significance
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level set to 5%, we required a minimum of 16 subjects to
detect a 15% change in M/Iclamp.
Statistical analyses
Data are presented as the mean and SD or standard error
of the mean (SEM) for western blot densitometries.
Fisher’s test for pair‐wise comparisons was used to ana-
lyse changes between measurements at baseline and at
follow‐up after 5weeks of acupuncture per‐protocol. A
p‐value<0.05 was considered significant.
Results
Clinical characteristics, treatment compliance and
side‐effects
In total, 21 women with PCOS were included and
underwent all baseline measurements and started treat-
ment (Supplemental Figure 1). Four dropped out after
one to six treatments and did not return for follow‐up,
leaving 17 women who were included in the analysis.
The reasons for dropout were time constraint (n=3) and
starting a pharmacological treatment (n=1). The number
of treatments varied from 11 to 19. Few side effects of
the acupuncture treatment were reported, and the most
common were temporary pain and bruises. Nine women
fulfilled all three diagnostic criteria of PCOS, one pre-
sented with hyperandrogenism and oligomenorrhea, two
presented with hyperandrogenism and PCO morphology,
and six presented with oligomenorrhea and PCO mor-
phology. The low number of participants did not allow
sub‐group analyses. Baseline characteristics of the study
participants are presented in Table 1.
Changes after 5weeks of electroacupuncture
Five weeks of electroacupuncture did not significantly af-
fect whole‐body glucose homeostasis as measured by
M/Iclamp (Figure 1A). HbA1c decreased by 9.5% (p=
0.004) (Figure 1B), and the fasting‐derived markers of in-
sulin resistance (HOMA‐IR and C‐peptide index) tended
to decrease (p=0.051 for both) after 5weeks of treatment
(Table 1).
Circulating testosterone decreased by 22% and DHT
by 12% after 5weeks of electroacupuncture treatment
(p=0.0007 and p=0.007, respectively) (Figure 1C–D), with
no changes in androstenedione, DHEA, E1, E2 or proges-
terone (Table 1). Because electroacupuncture has been
shown to decrease circulating sex steroids in several
studies (12,13), we used the highly sensitive and specific
GC‐MS/MS method to analyse adipose tissue
concentrations (for the first time) of the same panel of
sex steroids as in circulation. Adipose tissue concentra-
tions of testosterone decreased by 18% and androstene-
dione by 13% after 5weeks of treatment (p=0.049 and p
=0.035, respectively) (Figure 1E–F), with no changes in
DHT, DHEA, E1, E2 or progesterone (Table 1). Although
not significant, adipocyte size tended to decrease after
5weeks of treatment (p=0.092) (Table 1). All of these
changes occurred without affecting weight or any other
anthropometrics.
Dopamine turnover was measured because the effect
of electroacupuncture, at least in part, has been shown
to be mediated via changes in the autonomic nervous
system. Serotonin decreased by 21% and HVA by 20%
after 5weeks of electroacupuncture (p=0.027 and p=
0.011, respectively) (Figure 2A–B). The plasma levels of
dopamine, noradrenalin and DOPAC were below the level
of detection of the HPLC system.
Further, NGF, a marker of sympathetic activity, was
analysed in adipose tissue and we found an increase in
the ratio ofmNGF to pro‐NGFprotein after 5weeksof treat-
ment (Figure 3C). The most expressed forms of pro‐NGF
were the 50kDa form (Figure 3D), which represents a
major glycosylation state, and the 34kDa form, which cor-
responds to the pro‐NGF‐A splicing variant, and neither of
these changed after 5weeks of electroacupuncture
(Figure 3E–G). The expression of phosphorylated TrkA,
which is the receptor of pro‐NGF and mNGF, was signifi-
cantly increased by electroacupuncture indicating the
activation of TrkA downstream signaling pathways
(Figure 3H–I), but there was no change in the protein
expression of the p75NTR receptor (Figure 3H, J).
Discussion
Persons with impaired glucose tolerance and compensa-
tory hyperinsulinemia are at increased risk of developing
type 2 diabetes and should be referred to lifestyle man-
agement programs, including physical exercise and die-
tary advice, to improve their insulin sensitivity (29,30).
The increasing referrals to different complementary and
alternative treatments indicate a shift towards non‐drug‐
based therapies to complement more conventional ap-
proaches for improving health (31). To increase our
knowledge of the effect and mechanism of action of one
such treatment, we investigated the effect of low‐fre-
quency electroacupuncture as an alternative to lifestyle
management. We focused on overweight and obese
women with PCOS and found that 5weeks of
electroacupuncture improved HbA1c even though there
was no change in peripheral insulin sensitivity (M/Iclamp
value). Improved glucose regulation is supported by the
non‐significant decrease in HOMA‐IR and CPI, two
430 Electroacupuncture improves HbA1c in PCOS E. Stener‐Victorin et al. Obesity Science & Practice
© 2016 The Authors
Obesity Science & Practice published by John Wiley & Sons Ltd, World Obesity and The Obesity Society. Obesity Science & Practice
markers believed to primarily reflect hepatic insulin sensi-
tivity (32), and suggests that electroacupuncture im-
proves hepatic insulin sensitivity. These changes
occurred together with a decrease in circulating and adi-
pose tissue concentrations of androgens. The decrease
in HbA1c is equivalent to un‐supervised exercise in per-
sons with impaired glucose tolerance (33). Remarkably,
the changes observed in our study occurred with no
changes in body weight or waist circumference.
It is well known that physical exercise with muscle con-
traction is an effective strategy to prevent and treat type 2
diabetes (34). Exercise in insulin‐resistant and
overweight/obese women with PCOS improves insulin
sensitivity (28,35) and reduces fat content (35), and this
effect does not appear to be related to changes in
mitochondrial variables (36).
This study is the first to translate the experimental
findings in the DHT‐induced rat PCOS model (25) into
the clinical situation by demonstrating that
electroacupuncture has the potential to improve HbA1c
in overweight and obese women with PCOS. The
decrease in HbA1c by electroacupuncture is in agreement
with the decrease observed with short bouts of moderate
to vigorous‐intensity physical activity in persons at risk for
type 2 diabetes (37) and is aligned with physical activity
guidelines for at‐risk persons (38).
Table 1 Changes from baseline to after 5weeks of electroacupuncture (EA) treatment (three treatments/week) in women with PCOS
Variable Baseline (n=17) After EA (n=17) Δ (After Baseline) p *
Body composition
Body mass index (kg/m2) 30.8±4.20 30.8±3.84 −0.012±0.77 0.952
Weight (kg) 85.1±14.6 83.2±17.3 −1.84±6.59 0.314
Waist circumference (cm) 95.5±10.1 95.4±9.23 −0.12±2.39 0.921
Hip circumference (cm) 110.8±8.34 110.3±7.71 −0.47±3.06 0.586
Waist‐to‐hip ratio 0.86±0.074 0.87±0.08 0.003±0.02 0.751
Fat mass (%) 34.6±9.74 34.4±9.00 −0.19±1.53 0.638
Lean mass (%) 50.5±5.41 50.6±5.21 0.10±1.15 0.723
Adipocyte volume (µm3) 117.28±9.07 112.34±12.48 −4.93±11.52 0.098
Ferriman Gallwey score 10.4±7.17 11.1±8.34 0.50±3.69 0.492
Metabolic variables
ApoA1 (g/L) 1.40±0.24 1.39±0.22 −0.01±0.09 0.516
ApoB (g/L) 0.88±0.26 0.83±0.22 −0.04±0.16 0.272
ApoA1/ApoB ratio 0.65±0.18 0.64±0.20 −0.006±0.17 0.877
Cholesterol (mmol/L) 4.69±1.36 4.56±1.21 −0.13±0.70 0.434
Triglycerides (mmol/L) 1.15±0.51 1.10±0.56 −0.05±0.34 0.556
Glucose (mmol/L) 4.91±0.33 4.92±0.30 0.00±0.23 0.811
Insulin (mU/L) 12.4±6.89 11. 2±5.57 −0.18±5.03 0.408
HOMA‐IR 3.08±1.92 2.46±1.61 −0.62±1.21 0.051
C‐peptide (ng/mL) 1.28±0.52 1.15±0.45 −0.13±0.34 0.137
C‐peptide index 8.91±4.05 7.65±3.20 −1.26±2.35 0.051
Endocrine variables
LH (IU/L) 6.81±5.36 7.79±9.25 0.94±8.79 0.798
FSH (IU/L) 3.96±1.39 3.96±1.87 −0.001±2.70 0.981
LH/FSH ratio 1.75±1.25 1.66±1.43 −0.08±1.11 0.831
SHBG (nmol/L) 38.2±14.9 36.9±15.3 −1.23±7.31 0.506
Progesterone (pg/mL) 1436±2877 2486±3776 1049±5376 0.432
DHEA (pg/mL) 6732±3101 8087±5417 1354±4068 0.191
E1 (pg/mL) 66.3±29.0 65.8±29.6 −0.49±28.1 0.943
E2 (pg/mL) 76.8±37.7 71.1±47.6 −5.64±55.5 0.680
Adipose tissue sex steroids
Progesterone (pg/g) 12,382±24,960 27,152±38,813 14,769±52,528 0.246
DHEA (pg/g) 23,439±10,646 24,252±10,841 813±7080 0.943
E1 (pg/g) 522±273 570±280 47.8±229 0.407
E2 (pg/g) 162±116 707±1960 561±1963 0.084
All values are means±SD.
*: Fisher’s test for pair‐wise comparisons (baseline vs. after 5weeks of low‐frequency EA).
ApoA1, apolipoprotein A1; ApoB, apolipoprotein B; DHEA, dehydroepiandrostenedione; E1, estrone; E2, estradiol; FSH, follicle stimulating hor-
mone; HOMA‐IR, homeostasis model assessment of insulin resistance; LH, luteinizing hormone; SHBG, sex hormone binding globuline.
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Circulating testosteroneandDHT levelsweredecreased
by 5weeks of electroacupuncture. This is in line with our
previous observations in two independent randomized
controlled trials in which menstrual frequency and ovula-
tion frequency were also improved by electroacupuncture
(12,13). Together with the marked decrease in circulating
testosterone and DHT, we also found a tendency for a
decline in adipocyte size. The novelty of the present study
is that we measured subcutaneous adipose tissue sex
steroid concentrations with the highly sensitive and spe-
cific GC‐MS/MS method, and we found that androstene-
dione and testosterone concentrations were significantly
lower after 5weeks of treatment, mimicking the decrease
in circulating androgens. The reduction of both circulating
Figure 1 Changes in A) euglycemic hyperinsulinemic clamp (M/Iclamp); B) HbA1c; C) circulating testosterone; D) circulating dihydrotestosterone
(DHT); E) subcutaneous adipose tissue concentrations of testosterone and F) subcutaneous adipose tissue concentrations of androstenedione
after 5weeks of electroacupuncture (EA).
Figure 2 Changes in plasma levels of A) serotonin and B) homovanillic acid (HVA) after 5weeks of electroacupuncture (EA).
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and adipose tissue concentrations of androgens by
electroacupuncture might indicate decreased production
of ovarian testosterone, which in turn decreases subcuta-
neous adipose tissue concentrations and reflects the
modulation of sex steroid‐inactivating enzymes in
adipose tissue. These assumptions require further inves-
tigation. The adipose tissue is known to play a central role
in determining whole‐body insulin sensitivity, and it has
been shown that testosterone induces selective insulin
resistance in female subcutaneous adipose tissue (39).
Thus, decreased circulating and subcutaneous adipose
tissue concentrations might directly modulate glucose
regulation as reflected by a decrease in HbA1c and a
tendency for decreased HOMA‐IR and CPI.
Because the effect of electroacupuncture is at least in
part mediated via modulation of sympathetic nerve activ-
ity (14,16) and vagal activity (20), we analysed the adipose
tissue protein expression of NGF. It has been shown that
mNGF is a major regulator and activator of sympathetic
drive towards peripheral organs and that it is involved in
adipocyte metabolism in vitro (40), and that proNGF is
able to activate both TrkA and p75NTR‐related signaling
pathways (41). In the present study, the adipose tissue
mNGF/proNGF ratio was increased after 5weeks of
electroacupuncture, indicating that mNGF activity was
stimulated. Consistent with this, the phosphorylation of
TrkA, which is the high‐affinity receptor for mNGF, was
also increased by 5weeks of electroacupuncture, indicat-
ing that the activation of a mNGF/TrkA‐mediated down-
stream signalling pathway might contribute to the
electroacupuncture‐mediated improvement of glucose
regulation and the circulating and adipose tissue concen-
trations of androgens. Serotonin affects glucose homeo-
stasis and insulin resistance by acting via vagal afferent
serotonergic neurons and receptors in peripheral tissue
and is increased in type 2 diabetes patients (42), and
HVA is responsive to changes in blood glucose levels
(43). Thus, it is important to note that both of these
decreased indicating that electroacupuncture was able
to modulate the vagal system.
Considering that only a singlegroupwasstudiedand the
exploratory/experimental nature of this study, the effect of
the treatment might not be an actual effect but a statistical
artifact. This underlies the importance of performing
Figure 3 Changes in adipose tissue expression of A) pro nerve growth factor (proNGF), B) mature NGF (mNGF) and C) the mNGF/proNGF ratio
after 5weeks of electroacupuncture (EA) measured by ELISA. D) Representative blot of each proNGF splicing variant from before and after 5
weeks of EA measured by western blot and corresponding densitometry analyses for E) proNGF 50kDa; F) proNGF 34kDa and G) all proNGF
variants detectable in adipose tissue, and H) representative western blots and corresponding gel densitometry analyses for adipose tissue
expression of the mNGF/proNGF receptors I) phosphorylated‐TrkA and J) p75NTR.
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controlled studies. Thus, the limitationsof this studyare the
lack of a comparison group and its small sample size.
Basedon these findings,wehavenowbeenable toperform
a formal sample size estimation and have initiated a ran-
domized controlled study (Clinicaltrial.gov:
NTC02647827).
In conclusion, this study has shown that 5weeks of
electroacupuncture has a significant effect on improving
glucose regulation, including HbA1c and circulating and
adipose tissue androgen concentrations, an effect that,
at least in part, is mediated via activation of adipose
tissue sympathetic activity and modulation of the vagal
system.
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